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Abstract
Background: Mesenchymal stem cells are a promising cell source for chondrogenic differentiation and have been
widely used in several preclinical and clinical studies. However, they are prone to an unwanted differentiation
process towards hypertrophy that limits their therapeutic efficacy. Matrix metallopeptidase 13 (MMP-13) is a well-
known factor regulated during this undesirable event. MMP-13 is a collagen degrading enzyme, which is also highly
expressed in the hypertrophic zone of the growth plate and in OA cartilage. Accordingly, we investigated the effect
of MMP-13 inhibition on MSC hypertrophy.
Methods: In this study, 5-bromoindole-2-carboxylic acid (BICA) was used as an inhibitory agent for MMP-13
expression. After identifying its optimal concentration, BICA was mixed into a hydrogel and the release rate was
studied. To prepare the ideal hydrogel, chondroitin sulfate (CS) and platelet lysate (PL) were mixed with sodium
alginate (Alg) at concentrations selected based on synergistic mechanical and rheometric properties. Then, four
hydrogels were prepared by combining alginate (1.5%w/v) and/or CS (1%w/v) and/or PL (20%v/v). The
chondrogenic potential and progression to hypertrophy of human bone marrow-derived mesenchymal stem cell
(hBM-MSC)-loaded hydrogels were investigated under free swelling and mechanical loading conditions, in the
presence and absence of BICA.
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Results: Viability of hBM-MSCs seeded in the four hydrogels was similar. qRT-PCR revealed that BICA could
successfully inhibit MMP-13 expression, which led to an inhibition of Coll X and induction of Coll-II, in both free
swelling and loading conditions. The GAG deposition was higher in the group combining BICA and mechanical
stimulation.
Conclusions: It is concluded that BICA inhibition of MMP-13 reduces MSC hypertrophy during chondrogenesis.
Keywords: Chondrocyte hypertrophy, Platelet lysate, MMP-13 inhibitor, Small molecules, And mechanical properties
Introduction
Articular cartilage is a highly organized tissue with poor
self-healing ability caused by its avascular and aneural
structure [1–3]. Accordingly, cartilage defects are ex-
tremely common due to age-related problems, trauma,
or osteoarthritis (OA), leading to compromised cartilage
functionality [4, 5].
Available therapies have not yet been able to fully re-
store the biological and biomechanical function of dam-
aged cartilage [6]. Despite the rapid developments
regenerative medicine and tissue engineering have expe-
rienced in recent years, promising clinical applications
for cartilage regeneration are still lacking. The use of an
appropriate cell source is a key factor in tissue engineer-
ing. Bone marrow-derived mesenchymal stem cells (BM-
MSCs) have been widely used in cartilage tissue
engineering due to their relative ease of isolation, prolif-
eration capacity, and chondrogenic potential [7–14].
However, it has been shown that BM-MSCs tend to ac-
quire a hypertrophic phenotype, which is characterized
by the upregulation of Coll X and MMP-13 [15, 16].
The progression of MSCs towards a hypertrophic
phenotype is a major obstacle for the optimal clinical
use of MSCs for cartilage repair.
Among the biomarkers of chondrocyte hypertrophy,
Coll X and MMP-13 are the most widely used [17].
Coll X is normally expressed in the hypertrophic re-
gion of growth plate, but not in healthy cartilage;
however, it is overexpressed at the protein and
mRNA levels in OA human cartilage [18, 19]. MMP-
13 is an ECM-degrading enzyme, which is also highly
expressed in the hypertrophic zone of the growth
plate and in OA cartilage [17, 20].
In the present study, we investigated the effect of
MMP-13 inhibition on MSC hypertrophy. There are dif-
ferent ways to directly or indirectly suppress MMP-13
expression, such as small molecules or microRNAs
(miRNAs) [21–23]. Small molecules, as stable and cost-
effective agents [24], have been employed in different
clinical therapies [25].
Several types of MMP-13 inhibitor for OA and cancer
treatment have been investigated. Although they showed
good initial results, but they were unsuccessful in clinical
trials due to the off-target effects and musculoskeletal
syndrome after injection [26, 27]. Therefore, using a
construct for localized delivery of MMP-13 inhibitors
into the lesion may provide prolonged drug exposure
and limit their side-effects. Accordingly, within this
study, we investigated the effect of the small molecule
BICA loaded in a hydrogel on MMP-13 inhibition dur-
ing BM-MSC chondrogenesis.
Alginate is a hetero-polysaccharide made of linked β-
D-mannuronic acid and α-L-guluronic acid monomers,
extracted from brown sea algae [28–30]. Alg has been
extensively studied in biomedical applications especially
in tissue engineering owing to the biocompatibility, non-
toxicity, non-immunogenicity, good gel forming ability,
and low cost [28, 29, 31]. Previous studies indicated Alg
hydrogel provides an optimal milieu for chondrogenic
differentiation of encapsulated MSCs [30, 32–34]. How-
ever, Alg has shortcomings that include absence of cell
adhesion motifs and weak mechanical properties [31,
35–37]. Therefore, it is often used in combination with
other materials such as chitosan [38], hyaluronic acid
[39, 40], chondroitin sulfate [41], and synthetic polymers
(poly (lactic acid)) [31, 42] to improve its mechanical
and biological properties.
Chondroitin sulfate is a glycosaminoglycan made by
repeating disaccharide unit of D-glucuronic acid and N-
acetyl galactosamine sulfate. CS, as a main component
of cartilage extracellular matrix, plays an important role
in modulation of inflammation, control of cartilage me-
tabolism, intracellular signaling, linking extra cellular
matrix (ECM) with cell surface proteins, and cartilage
phenotype regulation [35, 43, 44]. It has been shown that
CS improves MSC chondrogenesis in hydrogels [45]. In
addition, the interaction of CS with Alg increases nega-
tive charge, providing more space for cell growth and
differentiation within the composite hydrogels [46].
Platelet lysate is a cocktail of growth factors, anti-
inflammatory cytokines, and clot-forming proteins that
are involved in tissue repair processes [47, 48]. PL is a
cost-effective and autologous source of growth factors
compared to recombinant growth factors [49]. Studies
suggest that PL significantly increases MSC proliferation
compared with fetal bovine serum (FBS) in vitro. It can
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also enhance the proliferative capacity of senescent
MSCs [50, 51]. In addition, PL enhances chondrogenic
differentiation of MSCs [52]. However, there are two
main drawbacks for PL as scaffold in tissue engineering:
a high degradation rate and low mechanical properties
[49, 53]. Therefore, the mechanical stability of PL-based
hydrogels for long-term applications needs to be im-
proved. In this study, we aimed to incorporate PL and
CS within an Alg gel to create a hydrogel matrix com-
bining the biological and mechanical properties of the
different materials.
Furthermore, it has been shown that mechanical load-
ing has a paramount effect on the development of ar-
ticular cartilage [54]. Chondrogenesis of MSCs has been
demonstrated under multiaxial loading in fibrin-
polyurethane scaffolds [55–57]. In addition, it has been
observed that the multi-complex mechanical forces, like
shear, compression, and torque were able to regulate the
expression of MMPs [58–60]. Therefore, we exposed
our constructs to a multiaxial load bioreactor, to exam-




5-Bromoindole-2-carboxylic acid (B2761), MTT powder
(M2128), α-MEM Powder, alginate sodium (Alg, A2033),
chondroitin sulfate (CS, C6737), calcium chloride
(CaCl2, 55670), phosphate buffer saline (PBS, P4417),
calcein AM (17783), ethidium homodimer-1 (46043),
and agarose (A0169) were obtained from Sigma, FBS
(Pan Biotech, Aidenbach, Germany).
Selection of the best CS and PL concentration
For choosing the best concentration of CS, we prepared
the hydrogel by blending a 1.5% (w/v) Alg with three dif-
ferent concentrations of CS 0.5, 1, and 2.5% (w/v), and
then, the hydrogels were incubated in agarose mold
wells (6 mm Ø × 3mm H) at RT. The agarose molds
were prepared from 3% w/v agarose in CaCl2 150 mM
for in situ gelling of the Alg solution. The obtained gels
were kept overnight in a solution of 150 mM CaCl2
before using for evaluation of mechanical properties by
compression testing. The hydrogels were also prepared
in a larger agarose mold of 25 mm Ø × 2mm H, for
rheology tests.
We also prepared the Alg hydrogel with different con-
centrations of fresh and freeze-dried PL. Briefly, three
different concentrations of fresh PL (10, 20, and 50% (v/
v)) and also three different concentrations of freeze-
dried PL (0.5, 1, and 2% (w/v)) were mixed with 1.5%
(w/v) sodium alginate, then cast into the agarose mold,
covered with 150 mM CaCl2, and incubated at RT.
Preparation of the PL was performed as follows:
Blood samples (300ml) were collected after obtaining
written consent from healthy volunteers according to
the ethical approval from Ethics Committee of Royan in-
stitute (IR.ACECR.ROYAN.REC.1395.174). The samples
were centrifuged at 200g for 30 min at RT. Then, the
resulting plasma supernatants were pooled, transferred
into a 15-mL Falcon tube, and centrifuged at 2000g for
5 min at RT to produce a platelet pellet. The platelet pel-
let was resuspended in PBS (1/10th of the initial blood
volume), sonicated for 15 min at RT, and then stored at
− 20 °C to use later as PL.
Compression mechanical test
Unconfined hydrogels were compressed using an Instron
5866 electromechanical test device equipped with a
static load cell of 100 N, at a displacement of 1 mm/min
and stopped at 50% sample’s height (n = 6). Young’s
modulus was calculated according to the stress-strain-
curve.
Rheological analysis
The viscoelastic properties of the various hydrogel
formulations were investigated using an Anton Paar
MCR-302 rheometer equipped with a Peltier
temperature control unit and cone-plate geometry (Dis-
posable Measuring Plate PP25 with a 25-mm diameter).
A fixed gap of 0.8 mm was selected, and a time sweep
was conducted at 100% strain at 25 °C. The storage
modulus (G′) and loss modulus (G″) values were calcu-
lated at 0.1% strain (n = 6).
Hydrogel preparation and characterization
Hydrogel was prepared by mixing alginate sodium
solution, CS, and PL to a final concentration of 1.5% (w/
v) Alg, 1% (w/v) CS, and 20% (v/v) PL. The aqueous
hydrogel mixture was cast into the agarose mold,
covered by 150 mM calcium chloride (CaCl2), and incu-
bated at room temperature (RT) overnight before
characterization. The detailed hydrogel formulations are
shown in Table 1.
The mechanical properties of cell-free and BM-MSC
embedded hydrogels were assessed. hBM-MSCs were
embedded in hydrogels (5 × 106/ml), and the mixture
was incubated in a solution of 150mM CaCl2 for 1 h
prior to mechanical analysis (n = 3).
Determination of ideal concentration of BICA
Cell viability evaluation
Cell toxicity of BICA was evaluated in duplicate using
MTT assay at two time points (days 3 and 7). hBM-
MSCs were isolated from bone marrow samples (2
donors aged 56 and 60 years old) according to the
ethical approval from Ethics Committee of Royan in-
stitute (IR.ACECR.ROYAN.REC.1395.174). Briefly
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bone marrow aspirates were harvested during routine
procedures from each patient’s iliac crest; after isola-
tion, hMSCs were subcultured an initial cell density
of 1 × 104 cells/cm2 in α-MEM supplemented with
15% fetal bovine serum (FBS) and 100 mg/mL penicil-
lin–streptomycin. The cells were expanded through
subcultures until passage 3 to use for other proce-
dures. The cells were also characterized in terms of
trilineage differentiation and expression of some sur-
face markers (CD44, CD73, CD105, CD90, CD11b,
CD45, and CD34). hMSCs were cultured in a 24-well
plate at a density of 1 × 104 cell/cm2 in α-MEM sup-
plemented with 10% FBS and six different concentra-
tions of BICA (1, 10, 20, 31, 39, and 50 μM). Cells
were washed with PBS followed by removing the
culture medium, then incubated in 0.5% of 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) for 2 h at 37 °C in a 5% CO2 atmosphere in-
cubator. MTT was replaced with an equal volume of
DMSO to dissolve the formazan crystals. Absorbance
was measured at 540 nm by a Multiskan Spectrum
microplate reader (ThermoScientific, USA).
Effect of BICA on chondrogenesis of hBM-MSC
In order to investigate the effect of BICA on chondro-
genic differentiation, standard pellet culture method was
used [61]. Briefly, hBM-MSC pellets were formed by
centrifuging 2.5 × 105 hBM-MSCs at 300g for 5 min in
chondrogenic culture medium; high glucose DMEM
supplemented with ITS (1%), ascorbic acid (50 μg/ml),
non-essential amino acid (1%), Dexamethasone (10− 7
M), L-glutamine (2 mM), and TGF-β1 (10 ng/ml). Six
different concentrations of BICA, as above, were added
to the chondrogenic medium. A control group without
BICA was also prepared. The medium was changed
every 3 days until the pellets were harvested at day 28
for further analysis. The collected media were also
pooled and kept at 4 °C until further investigation.
Biochemical analysis for glycosaminoglycan, collagen,
and DNA content assay Glycosaminoglycan (GAG)
assay was performed on intact pellets (INT) and the
conditioned media (CM). Pellets were rinsed with PBS
and digested overnight in proteinase-K (0.5 mg/ml) at
56 °C. DMMB (1,9-dimethyl-methylene blue) was used
in order to quantify the sulfated glycosaminoglycan.
Briefly, 200 μl of DMMB color reagent was added to
20 μl of sample or chondroitin sulfate standard. The
absorbance was measured immediately at 535 nm. The
results were normalized to the DNA content quantified
by PicoGreen assay on the same proteinase-K digest as
above. For this purpose, PicoGreen was added to each
sample or DNA standard and incubated at RT for 5 min.
The fluorescence was measured at excitation 485 nm
and emission 535 nm. On the same digested samples,
the collagen content was evaluated with Sircol™ Insol-
uble Collagen Assay kit, according to the manufacturer’s
instructions. Briefly, 1 ml Sircol dye reagent was added
to 50 μl of sample or standard and gently mixed on a
mechanical shaker for 30 min. The tubes were drained
followed by centrifugation at 12,000 rpm for 10 min. The
pellet was dissolved in Alkali reagent after removing the
unbound dye with an ice-cold Acid-Salt Wash reagent.
The absorbance was recorded at 550 nm, and the results
were normalized to the DNA content. All absorbance/
fluorescence measurements were performed by a Victor3
micro plate reader. GAG, Collagen, and DNA assays
were done in triplicate.
Real-time PCR analysis The pellets were washed with
PBS and snap frozen in liquid nitrogen. Total RNA was
extracted using TRI Reagent (Molecular Research Center
TR-118, Cincinnati, USA). Reverse transcription was
performed with random hexamer primers and TaqMan
reverse transcription reagents. All real-time quantitative
polymerase chain reactions (PCR) for the pellet culture
studies were performed with a SYBR Premix Ex TaqTM
II (TaKaRa RR820L, Kusatsu, Japan) on an ABI StepO-
nePlusTM Q-PCR system (applied Biosystems Life
Technologies) for Coll X and MMP-13 genes. The ex-
pression level of target genes was normalized to β-actin
as the reference gene. The analysis was performed by
the comparative ΔΔCT method. Primers are listed in
Table S1(supplementary material).
Histological evaluation hBM-MSC pellets were fixed in
4% paraformaldehyde and incubated in 4 °C for 3 days.
After processing in a tissue preparation machine (Did
Sabz co, Iran), the samples were embedded in paraffin.
Table 1 List of hydrogel formulations
Hydrogel description Alginate (%w/v) Chondroitin Sulfate (%w/v) PL
Alg 1.5 0 0
Alg-CS 1.5 0.5, 1, 2.5 0
Alg-PL 1.5 0 Freeze-dried: 0.5, 1, 2 (%w/v)
Fresh: 10, 20, 50 (%V/V)
Alg-CS-PL 1.5 1 Fresh: 20(%V/V)
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Six-micrometer sections were stained with safranin O
and fast green and toluidine blue.
Release kinetics of BICA in tri-part hydrogels
In order to examine the kinetic release of BICA,
alginate-based hydrogels were used. The best concentra-
tion of BICA was added into four hydrogels with differ-
ent compositions (Table 1). The hydrogels were
prepared in the cap of a 1.5-mL Eppendorf tube and
cross-linked with a 150 mM CaCl2 solution at RT for 1
h. The remaining solution was stored to calculate the
amount of non-encapsulated drug. The BICA-
embedded hydrogels were incubated in 1 ml PBS at
37 °C (n = 3). Aliquots from the 1 ml PBS solution
were collected and replaced with 1 ml fresh PBS at
specific time points, and the BICA concentration was
determined by a Thermo Scientific™ Multiskan™ GO
Microplate Spectrophotometer (Thermo Scientific™,
USA) at a wavelength of 290 nm.
Embedded hydrogels with mesenchymal stem cells
Human BM-MSCs were isolated from bone marrow
samples (3 donors aged 15, 18, and 37 years) after ethical
approval from the cantonal ethical commission of Bern
(KEK: Req-2016-00141) using previously described pro-
tocols [62]. Bone marrow samples were aspirated of ver-
tebral bodies from each donor, after isolation, at 70–80%
confluence, hBM-MSCs were harvested by trypsinization
and subcultured at a density of 3 × 103 cells/cm2 in
Minimum Essential Medium supplemented with 10%
Sera Plus bovine serum, 100-U/mL penicillin, and 100-
mg/mL streptomycin, and 5 ng/ml FGF and grown until
passage 3. Cultures were maintained at 37 °C/5% CO2,
and the medium was refreshed every second day. hBM-
MSCs were also seeded into the hydrogels at a density of
5 × 106 cell/ml at passage 3. The cell-laden hydrogels
were cast into a mold (8 mm Ø × 5mm H) and incu-
bated in 150mM CaCl2 for 1 h at RT. Then, washed
with PBS and incubated in chondrogenic culture
medium for more analysis.
Live and dead assay
After embedding hBM-MSCs into the Alg-based hydro-
gels, the cell-laden constructs were cultured in αMEM
supplemented with 10% v/v SeraPlus, 1% v/v of Pen/
Strep, and 5 ng/ml recombinant human fibroblast
growth factor-2 (FGF-2). Then, cell viability was assessed
at 2 time points (days 3 and 7) on the bulk hydrogel,
using live/dead assay, where living cells were stained
with Ca-AM and dead cells with EthD-1. At each time
point, the hydrogels were removed from the culture
medium and incubated in a staining solution containing
5 μM Ca-AM and 1 μM EthD-1 prepared in serum-free
DMEM LG for 1 h at 37 °C, within a humidified
atmosphere of 5% CO2. After incubation, cells were im-
aged with confocal laser scanning microscopy (LSM810,
Zeiss). For each sample, single plane and Z stack
(1300 μm) were acquired and tile scans were generated
to image a larger sample area. Four different fields of
view per sample were used to quantify cell viability by
counting the red (dead) and green (viable) cells in Image
J software.
Chondrogenesis assessment
Chondrogenic differentiation of cell-laden hydrogels
(with and without 39 μM BICA) was investigated by
qRT-PCR, biochemical assessment, and histological
staining after 28 days. Total RNA was isolated using TRI
Reagent® Solution (Molecular Research Centre Inc., Cin-
cinnati, OH, USA) according to the manufacturer’s
protocol. Reverse transcription of 1 μg total RNA was
performed by TaqMan Reverse Transcription Kit
(Applied Biosystems, Foster City, USA). Relative gene
expression (quantitative polymerase chain reaction
(qPCR)) reactions were set up in 10-μL reaction
mixtures containing TaqMan Universal Master Mix
(Thermo Fisher, Zürich, Switzerland), the appropriate
set of primers and probes, DEPC-H2O and cDNA tem-
plate. For gene expression, Coll I, Coll II, ACAN, ALP,
Coll X, and MMP-13 were evaluated, and 18S was used
as a housekeeping gene. The expression of genes was
normalized to a control of encapsulated hBM-MSCs into
Alg- hydrogel, incubated for 24 h. Technical triplicates
were used for each target gene and for the different do-
nors (n = 3). Primer and probe sequences are shown in
supplemental Table S2 (supplementary material), while
catalog numbers of Assays-on-Demand (Applied Biosys-
tems, Foster City, USA) are listed in the supplemental
Table S3 (supplementary material). GAG and collagen
content in the samples were normalized to DNA con-
tent. In addition, GAG in the conditioned medium was
also measured. Histological staining analysis was
performed.
The effect of mechanical loading on the chondrogenesis
of hBM-MSCs in hydrogels
Chondrogenesis of hBM-MSCs in the best hydrogel
(Alg-CS-PL with and without 39 μM BICA) was evalu-
ated in the presence or absence of mechanical loading.
The mechanical loading was produced by multiaxial
loading bioreactor [63]. Briefly, a ceramic ball (32 mm in
diameter) was pressed onto the scaffold. An interfacial
shear load was generated by ± 25° oscillatory rotation of
the ball about the axis perpendicular to the scaffold’s
axis (at a fixed indentation of 0.2 mm with a frequency
of 0.1 Hz). After an initial 2-week culture without load-
ing, mechanical stimulation was applied 1 h per day for
five consecutive days per week over a period of 2 further
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weeks. After a total of 4 weeks’ culture, samples were
harvested for qRT-PCR, histology, and biochemical ana-
lyses (2 different donors with 2 replicates).
Statistical analysis
Data were obtained from the samples and represented as
the mean ± standard deviation (SD). Statistical assess-
ment was carried out by analysis of two-way ANOVA
and post hoc Tukey’s tests. Statistical analysis was per-
formed by means of Prism software (GraphPad Software,
La Jolla, CA, USA).
Results
Determination of CS and PL concentration for
combination with Alg hydrogel
Mechanical testing and rheological measurements were
used to select the best concentration of CS and PL to in-
corporate with Alg. Figure 1a shows compressive stress-
strain curves for Alg hydrogel (1.5% w/v) with 3 different
concentrations of CS (0.5, 1, 2.5% w/v). The Young’s
modulus calculated from stress-strain curves (Fig. 1b)
shows a significant increase in the Alg hydrogel with
CS-1% (1245.7 Pa ± 92.45) compared with Alg hydrogel
alone (869.1125 Pa ± 265.52) (P ≤ 0.01) and Alg incorpo-
rated with CS-2.5% (927.724 Pa ± 83.46) (P ≤ 0.05).
Figure 1c indicates the rheological measurement of
hydrogels with three concentrations of CS, while Fig. 1d
shows the G′ and G″ calculated at 0.1% strain of rheom-
eter assessment. Our results demonstrated that the Alg
hydrogel with CS-1% had significantly higher G′ and G″
compared with 0.5 and 2.5% CS hydrogels (p ≤ 0.001)
(Fig. 1d). Furthermore, the hydrogels with 0.5 and
2.5% CS showed significantly lower G′ and G″ in
comparison to the Alg hydrogel alone (P ≤ 0.001). To
this end, Alg hydrogel with CS-1% was selected for
further investigation.
Figure 2a shows compressive stress-strain curves for
Alg hydrogels with three different concentrations of
freeze-dried PL and three different concentrations of
fresh PL. Figure 2b shows a significantly higher Young’s
Fig. 1 Mechanical properties of hydrogels with different concentrations of CS. a Compressive stress-strain curve. b Young’s modulus. The results
showed higher Young’s modulus in the Alg-CS-1% compared with Alg and Alg-CS-2.5% hydrogels (*, # presented a statistically significant
differences compared to Alg-CS-1% with P ≤ 0.01, P ≤ 0.05 respectively). c Rheological measurements. d G′ and G″ calculated at 0.1% strain. The
elastic (G′) and viscous (G″) modulus were significantly higher in the Alg-CS-1% hydrogel compared with Alg hydrogels containing CS (0.5, 2.5%).
The Alg hydrogels with CS 0.5% and 2.5% had significantly lower G′ and G″ compared with Alg hydrogel (*, # presented a statistically significant
difference compared to Alg-CS-1% and Alg hydrogels, respectively (p ≤ 0.001)) (n = 6)
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modulus in the Alg with PL-fresh-20%(v/v) (1092.436
Pa ± 27.408) compared with Alg hydrogel (783.99 Pa ±
20.18) (P ≤ 0.05). There was no statistically significant
difference between other groups. In addition, Fig. 2c
shows the rheological measurement of hydrogels with
different concentrations of PL (freeze-dried and fresh),
and Fig. 2d shows the G′ and G″ calculated at 0.1%
strain of rheometer assessment. The results indicated
that hydrogels with different concentrations of PL, both
fresh and freeze-dried, had significantly higher G′ com-
pared with Alg hydrogel alone (P ≤ 0.01).
Similarly, hydrogels at all concentration of fresh PL
showed significantly higher G″ in comparison to the Alg
hydrogel (P ≤ 0.05). There was no significant difference
in G″ between freeze-dried PL and Alg hydrogel. The
fresh PL 20% was selected for further investigation based
on the Young’s modulus value (1092.436 Pa ± 27.408).
Mechanical compression analysis of alginate-based
hydrogels containing CS and PL
Three different hydrogels were prepared by incorporating
of CS (1% w/v), PL (20% v/v), or both with Alg hydrogel
(1.5% w/v). An unmodified Alg hydrogel was used as a
control. Figure 3a shows hydrogel strain-stress curves,
while Young’s modulus is shown in Fig. 3b. The results in-
dicated a significant increase of Young’s modulus in Alg
incorporated CS, and PL or both compared with Alg alone
(p ≤ 0.05). No significant difference between cell laden
hydrogels and hydrogels without cells was observed.
The viscoelastic properties of the alginate-based
hydrogels were also assessed. The G′, G″ versus strain
are shown in Fig. 3c. The results showed at 0.1% strain
higher G′ (p ≤ 0.01) and G″ (p ≤ 0.05) in Alg-PL hydro-
gels in comparison to the other hydrogels (Fig. 3d).
Selecting the effective concentration of BICA
The cytotoxicity of BICA in monolayer was investigated by
MTT assay. The results indicated that all the tested con-
centrations of BICA had no adverse effect on the metabolic
activity of hBM-MSCs at defined times (days 3 and 7).
Figure 4a shows the absorbance of formazan-dissolved so-
lution at 540 nm in control and treated groups.
The effect of BICA on chondrogenesis was investi-
gated in pellet culture over 28 days. The gene expression
Fig. 2 Mechanical properties of hydrogels with different concentrations of PL. a Compressive stress-strain curve. b Young’s modulus calculated
from A curves shows a significant increase in Alg with fresh-PL-20% (v/v) hydrogel compared with Alg hydrogel alone (* P ≤ 0.05). c Rheological
measurements. d G′ and G″ calculated at 0.1% strain. The results showed significant higher elastic (G′) modulus in the Alg-PL hydrogels (all
concentrations) compared with Alg hydrogel alone (* p≤ 0.01), and viscous (G″) modulus were significantly higher in all the Alg-PL hydrogels
(fresh ones) compared with Alg hydrogel alone (#p≤ 0.05) (n = 6)
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level of two hypertrophy-associated genes (MMP-13 and
Coll X) was evaluated by qRT-PCR. The relative expres-
sion of MMP-13 showed a significant decrease at 39 μM
BICA compared to the other groups (P ≤ 0.001) (Fig. 4b).
Similarly, the lowest expression of Coll X was also ob-
served at the BICA concentration of 39 μM (P ≤ 0.001)
(Fig. 4c).
GAG and collagen content of hBM-MSC pellets that
were cultured with BICA was also evaluated. At BICA
concentrations of 20 μM and 39 μM, GAG secretion was
greater than the control group (P ≤ 0.001) (Fig. 4d). The
highest collagen content was observed at 39 μM BICA,
which was significantly compared to other groups except
for the control group and 20 μM BICA (Fig. 4e). Histo-
logical staining was performed on pellets with different
concentrations of BICA. Chondrogenic differentiation
was observed in hBM-MSC pellets cultured in chondro-
genic media with and without BICA (Fig. 4f). Following
these results, the concentration of BICA of 39 μM was
selected for further studies.
In vitro release study
In vitro release of BICA from hydrogels was studied
for 9 days. The release profile showed a burst release
of 28–33% of BICA within the first 2 h for all groups.
Then, a similar sustained release profile was observed
for all groups. After 72 h, between 36 and 43% of
BICA were released from all the 4 hydrogels. A near-
plateau profile was observed for all groups until day 9.
(Fig. 5a and b).
Live-dead assay for cell containing alginate-based
hydrogels
To evaluate whether the crosslinked Alg-based hydrogels
affect cell viability, we encapsulated hBM-MSCs within
different hydrogels and cultured them for 1 week.
Hydrogel constructs were then stained with Live-Dead
dye staining at 2 time points (day 3 and 7). As shown in
Fig. 6a and b, no decrease in cell viability was observed
in the different hydrogels.
Fig. 3 Mechanical properties of different hydrogels with or without cells. a Compressive stress-strain curve. b Young’s modulus calculated from
the stress-strain curve. The chart reveals a significantly higher Young’s modulus in the Alg gel containing either both fresh-PL-20% /CS1% or only
one of them when compared to Alg hydrogel with or without cells. No significant difference was observed in cell free hydrogels compared with
cell containing hydrogels (*, # presented a statistically significant difference compared to other groups in both conditions with or without cells
(p ≤ 0.05)). c Rheological measurements of four different hydrogels. d Calculated elastic (G′) and viscous (G″) modulus at 0.1% strain. The results
indicated significantly higher G′ and G″ in the Alg-PL hydrogel compared with the other hydrogels (* (p≤ 0.01), # (p ≤ 0.05)) (n = 3)
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Fig. 4 Selecting the effective concentration of BICA. a MTT assay showed no adverse effect at any concentration of BICA on the metabolic
activity of the hBM-MSCs cultured in pellets for 3 and 7 days. b After 28 days of chondrogenic pellet culture, the expression of MMP-13 gene at
39 μM was significantly lower than the other groups (***P≤ 0.001). c The expression of Coll X gene at 39 μM was significantly lower than all
groups, except for 1 μM and 50 μM (***P ≤ 0.001). d GAG production was significantly higher at 20 and 39 μM compared to the other groups (*, #
indicate a significant difference against 39 μM and 20 μM respectively). e Total collagen content was significantly higher at 39 μM (and control)
compared to the other groups (*, # indicate a significant difference against 39 μM and control respectively). f Toluidine blue and Safranin-O and
fast green staining of different concentrations of BICA on MSC pellet culture
Fig. 5 a Cumulative release rate of BICA in hydrogels. The sustained release pattern is similar for all hydrogels (n = 3). b Standard curve for BICA
at 290 nm
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Differentiation assessment for cell laden hydrogels
qRT-PCR
In Fig. 7a, the expression of Coll II in Alg-CS-PL was
significantly greater than all the other groups, when no
BICA was present. Interestingly, in groups containing PL
and BICA, Coll II expression was significantly higher
compared to Alg- and Alg-CS groups. In all BICA-
containing groups, except Alg-CS-PL, the expression of
Coll II is significantly greater than the comparable
groups without BICA.
The expression of ACAN in Alg-CS-PL (with or with-
out BICA) was significantly higher than all other groups.
It is worth mentioning that no significant difference was
observed between groups with BICA in comparison to
without BICA (Fig. 7b).
In the absence of BICA, the expression of MMP-13 in
Alg-CS-PL and Alg-PL was significantly lower than Alg
and Alg-CS groups (p < 0.001). Moreover, the expression
of MMP-13 in Alg was significantly greater than Alg-CS
(p < 0.001). A significant difference was also observed
between Alg and Alg-CS groups with BICA compared
with the same groups without BICA (p < 0.001). There
was no significant difference between BICA-containing
groups. (Fig 7c).
Fig. 6 Live-dead assay staining. a Live (green) and dead (red) cells in four different hydrogels at days 3 and 7 (scale bar = 100 μm). b Cell viability
percentage at days 3 and 7
Fig. 7 Chondrogenesis assessment in the presence or absence of 39 μM BICA. qRT-PCR was performed to investigate the expression of a Coll II, b
ACAN, c MMP-13, d Coll X, e ratio between Coll II and Coll X, f ALP, g Coll I, and h ratio between Coll II and Coll I in four different hydrogels at
day 28. Data are presented as means ± SD (n = 3) (*p < 0.05, **p < 0.01, ***p < 0.001)
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Coll X expression was similar in all groups without
BICA. While Alg with BICA had similar expression of
Coll X compared with BICA free samples, the addition
of BICA to Alg-CS and Alg-CS-PL significantly reduced
Coll X expression. BICA containing hydrogels demon-
strated a clear inhibition of Coll X (Fig. 7d). When com-
paring Coll II/Coll X ratio, in order to assess stability of
chondrogenic differentiation, in non-BICA groups, Alg-
CS-PL had an increased ratio compared with other
groups. Alg-CS also demonstrated a higher Coll II/Coll
X ratio compared to Alg hydrogels. In BICA-containing
hydrogels, the ratio of Coll II/Coll X in Alg-CS and Alg-
CS-PL were significantly greater compared with the two
other hydrogels. There was no significant difference be-
tween Alg-CS and Alg-CS-PL hydrogels. In addition, all
hydrogels containing BICA showed a significant increase
in Coll II/Coll X ratio compared to the same hydrogels
without the small molecule (Fig. 7e).
The expression of ALP in Alg-PL and Alg-CS-PL,
without BICA, was significantly lower than the other
groups. No significant difference was observed among
BICA-containing groups, although they showed signifi-
cantly lower ALP expression compared to the groups
without BICA (Fig. 7f).
The expression of Coll I in the Alg hydrogel without
BICA was significantly higher than all the other groups.
No significant difference was observed between the
groups containing BICA (Fig. 7g). It was found that Coll
II/ Coll I ratio in Alg-CS-PL hydrogel was significantly
higher compared with other non-BICA hydrogels. In
BICA-loaded groups, Alg-PL hydrogels had a greater
Coll II/ Coll I ratio compared with other groups. There
was also a significant difference in all BICA loaded gels
except Alg-CS-PL when compared with the same hydro-
gel without BICA (Fig. 7h).
Histochemical assay and histological staining
DMMB results revealed that GAG was retained within
the hydrogel matrix but most GAG was released into the
culture media. When BICA was absent, the GAG con-
tent for Alg-CS-PL was significantly greater than Alg-CS
and Alg. The Total GAG content for BICA-containing
groups was significantly higher than groups without
BICA(p ≤ 0.01), except for the Alg-CS-PL group. When
BICA was present, a significant difference was observed
between Alg and Alg-PL (Fig. 8a) (p ≤ 0.05).
Although no significant differences were observed be-
tween BICA-containing and BICA-lacking groups, when
BICA was present, the total collagen content in Alg-CS-
PL hydrogel was significantly greater in comparison with
Alg and Alg-CS (p ≤ 0.05). Alg-CS-PL without BICA also
showed increased collagen production in comparison
with Alg (p ≤ 0.05) (Fig. 8b).
Toluidine Blue and Safranin-O staining also demon-
strated glycosaminoglycan deposition within the extra-
cellular matrix by hBM-MSCs. In all conditions, there
were a production of an abundant extra cellular matrix
(ECM). (Fig. 8c).
Mechanical loading
The hydrogels containing the combination of Alg, CS,
and PL (with or without BICA) were selected as the
Fig. 8 Biochemical and histological assessment of chondrogenic differentiation in the presence or absence of 39 μM BICA at day 28. a GAG
produced by hBM-MSC-loaded hydrogels within conditioned media (CM) or within hydrogels (INT). b Total collagen content of hBM-MSC-loaded
hydrogels. c Toluidine blue and Safranin-O & fast green staining. Data are presented as means ± SD (n = 3) (*p < 0.05, **p < 0.01, ***p < 0.001)
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most appropriate hydrogel for investigation of mechan-
ical loading, due to their better performance at the
mRNA level, biochemical, and histological analysis. The
effect of mechanical loading on the hydrogels is
presented in Fig. 8. After mechanical loading, the
expression of Coll II was significantly higher in the
BICA-containing hydrogel (p ≤ 0.001). Furthermore, ex-
pression of the hypertrophy marker MMP-13 (p ≤ 0.01)
was significantly lower in BICA-containing groups than
in groups without BICA. The presence of BICA did not
affect the expression of Coll I, ALP, and ACAN under
mechanical loading. The ratio of Coll II/Coll X (p ≤ 0.05)
and Coll II/Coll I (p ≤ 0.01) in BICA-loaded was signifi-
cantly greater than non-BICA-loaded hydrogels. (Fig. 9a).
Mechanical loading induced GAG production with or
without BICA (Fig. 9b). Collagen secretion was not sig-
nificantly affected, neither by the presence of BICA nor
by mechanical loading. (Fig. 9c). Toluidine blue and
Safranin-O staining showed that hBM-MSCs produced
GAG with or without BICA. The images showed more
coherent tissue in the presence of the BICA (Fig. 9d).
Discussion
There are several key requirements regarding the
properties of the ideal scaffold for tissue engineering:
it should be biocompatible, non-cytotoxic, allow diffu-
sion of nutrients, mechanically stable, readily avail-
able, and adaptable to be implanted in lesions of
different sizes [35].
Alginate is extensively used in vitro, due to simple gel-
ation mediated by Ca2+ ions [64, 65], and has been used
for delivery of hMSCs in different tissue engineering ap-
plications such as cartilage [28, 66, 67]. However, Alg
lacks a cell binding domain [68], and hMSCs are
anchorage-dependent cells; their viability decreases if
they cannot bind to matrix. Furthermore, Alg provides
only a mechanical cue, with no biological cues such as
growth factors or bioactive molecules; additionally, Alg
is not a natural component of cartilage matrix.
Therefore, in the current study, PL, a potential autolo-
gous cocktail of proteins, growth factors, and anti-
inflammatory cytokines, and CS, a main cartilage
extracellular matrix component, were added to the
Fig. 9 The effect of mechanical loading on chondrogenesis of hBM-MSCs in Alg-CS-PL hydrogels in the absence or presence of 39 μM BICA at
day 28. a qRT-PCR of loaded samples normalized to unloaded samples. b GAG deposition of loaded and unloaded samples (−) without and (+)
with BICA. c Collagen content of loaded and unloaded samples. d Toluidine blue and Safranin-O and fast green staining of loaded samples with
and without BICA. Data are presented as means ± SD (n = 2) (*p < 0.05, **p < 0.01, ***p < 0.001)
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hydrogel in order to develop a more favorable MSC de-
livery system for cartilage regeneration.
Our results showed that the Young’s modulus of Alg
hydrogel increased by adding CS at a defined concentra-
tion (1% w/v). However, at higher concentration of CS, a
decreased Young’s modulus was observed. Huang et al.
indicated the incorporation of CS significantly increased
the storage modulus of the Alg-foams [33].
The rheological measurements in accordance with the
mechanical bulk testing showed that Alg hydrogel with
1% of CS had an increased viscoelastic property (G′ and
G″) in comparison with Alg. CS molecules have a re-
inforcing effect, hypothetically attributed to an increase
in polymer network density and water retention ability,
without disruption of the Alg network. However, by in-
creasing further the amount of CS within Alg hydrogel,
a reduction of G′ and G″ is observed, likely related to a
disruption of the ionic Alg crosslink network.
Combining CS with Alg increases the negative charge
within the hydrogel network and influences the system
arrangement by spatial occupation [69]. This potentially
causes an increased space between polymer chains and
decreases the mechanical properties of the hydrogels.
Stuart and Panitch showed that CS incorporation to a
collagen hydrogel decreased the viscoelastic properties
of the collagen hydrogel due to changes in void space
[70]. Furthermore, it was shown that the introduction of
a negatively charged polysaccharide such as GAG into
collagen hydrogels has different outcomes depending on
the molecular weight, ratio of GAG to collagen gel, and
ionic strength [71, 72].
We also added PL into the Alg hydrogel to improve the
biological properties for cartilage tissue engineering. There
have been several studies reporting PL to be a positive
stimulus for repairing/regenerating different tissues, such
as bone [73], skin [74], tendon [75], and cartilage [53].
However, two main problems remain: high degradability
rate and low mechanical properties. Combination of PL in
a hydrogel can protect growth factors and biomolecules
from degradation and allow their continuous release [47].
Babo et al. incorporated PL into HA hydrogels which re-
sulted in sustained release of growth factors and enhanced
the viability of cells either encapsulated in or seeded
within the hydrogels [76, 77]. Our results revealed that
addition of PL increased the Young’s modulus as well as
the viscoelastic modulus (G′, G″) of alginate hydrogel. It
is possible that the clotting proteins of PL and the positive
charges could enhance the alginate hydrogel crosslinking,
resulting in a stronger network. In addition, the viscoelas-
tic properties of the alginate gel with PL was higher than
that of CS incorporated alginate gel.
It is important to consider that the cellular behavior is
dependent on the hydrogel mechanical properties. Cells
can reorganize and re-engineer their environments
through mechanical and biochemical interaction with
the substrate. Therefore, cells can strongly influence the
hydrogel matrices in which they are embedded, in the
short term through interaction with the crosslinking
mechanism and long-term through remodeling [78–80].
There are few systematic studies that reported regarding
changes in hydrogel mechanical properties upon addition
of cells. For example, Buckley et al. showed increasing the
cell seeding density effectively lowers the initial mechan-
ical properties of a cell-seeded agarose hydrogel [81]. Our
results showed embedding cells in Alg-based hydrogels
does not change the Young’s modulus of the hydrogels.
Hu et al. demonstrated that Bortezomib, an FDA-
approved small molecule for the treatment of myeloma,
inhibits the expression of MMP-13, leading to a reduc-
tion of collagen type 2 degradation [82]. We based our
initial screening range around a previous study that pro-
posed 31 μM and 39 μm as suitable concentrations based
on the structure of BICA and the Fragment-Based
Screening study of Fragment-Based Discovery of Indole
Inhibitors of Matrix Metalloproteinase-13 [83]. We then
selected 39 μM based on our pellet-based screen. Inter-
estingly, no significant difference was observed between
groups in terms of cell viability.
Chondrogenic differentiation was evaluated for hBM-
MSC pellets in the presence of BICA at different con-
centrations. Our data demonstrated a dose-dependent
effect of BICA on hypertrophy and chondrogenesis of
hBMCs. Hereafter BICA at a concentration of 39 μM
was used for further studies.
Using a platform to deliver a drug directly to a lesion
site may decrease the off-target effects associated with
systemic drug injection by providing a prolonged but lo-
calized drug exposure [26, 27, 84]. An alginate-based
hydrogel was used in this study to investigate BICA de-
livery during MSC chondrogenesis. In vitro release of
BICA over nine consecutive days showed a similar trend
for BICA release from the four hydrogels tested, with
Alg-CS-PL having the lowest cumulative release com-
pared to Alg-CS and Alg-PL.
The viability of hBM-MSCs encapsulated in Alg-based
hydrogels was assessed. Previous studies have demon-
strated the positive effect of PL upon the viability and pro-
liferation of hBM-MSCs in combination with other
hydrogels such as hyaluronic acid [47] and gellan gum gels
[85], coating the scaffolds [86] and even used alone as a
hydrogel [50]. In addition, it has been shown that incorp-
oration of CS into the network supports the viability and
proliferation of chondrocytes for at least 6 weeks [87].
Our results showed incorporation of PL and CS supported
the viability of hBM-MSCs at day3, and 7. PL rescues the
viability of hBM-MSCs by introduction of growth factors
and CS as an enhancer of cell adhesion can protect cell
proliferation and survival [88].
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Chondrogenic differentiation of hBM-MSCs in the
four different hydrogels was also studied. In the absence
of BICA, expression levels of chondrogenic genes were
significantly increased in Alg-CS-PL in comparison with
other groups. Moreover, osteogenic genes such as ALP
and Coll I and MMP-13 as a hypertrophy gene were also
significantly decreased. This might be due to the
synergistic effect of PL and CS on chondrogenic differ-
entiation. As observed in previous studies, PL induces
chondrogenic differentiation of adipose-derived [89] and
umbilical cord-derived [52] MSCs. It has been shown
that PL-loaded hyaluronic acid stimulates chondrogene-
sis of hMSCs [90]. Moreover, it was demonstrated chon-
droitin sulfate, an important molecule in cartilage
extracellular matrix, improved chondrogenesis of MSCs
[43]. Besides, Nguyen et al. demonstrated that PL in-
duces reprograming of quiescent cartilage cells resulted
in new cartilage formation [91].
The expression of Coll X along with MMP-13 is typic-
ally expressed in the hypertrophy pathway. Interestingly,
unlike MMP-13, the results showed no effect the different
hydrogels on Coll X expression. It is well-known that the
expression of MMP-13 is controlled by different signaling
pathways [92, 93]. One of the important mechanisms is
the RUNX2 pathway that regulates both early (Coll X)
and late (MMP-13) hypertrophic markers [94]. On the
other hand, it has been demonstrated increased RUNX2
expression in articular chondrocytes may not be enough
to increase MMP-13 expression [94]. In this study, the
changes in MMP-13 and Coll X expression suggests PL
regulates MMP-13 expression in a different way compared
with Coll X, potentially in a Runx2-independent manner.
However, this would require a more detailed analysis. Due
to the transient and fluctuating nature of gene expression
changes during differentiation, additional time points may
be required to fully assess the gene expression changes.
Cell-hydrogel constructs were also used to study the ef-
fect of BICA on the inhibition of hBM-MSC hypertrophy.
When no BICA was present, GAG secretion in Alg-CS-
PL showed the highest value which confirmed the mRNA
results. Again, this suggests that PL and CS promoted
chondrogenesis of hBM-MSCs. Previous studies have also
indicated that CS can improve chondrogenic properties of
hydrogels [43, 44]. In addition, Hildner at al. demonstrated
GAG secretion of adipose-derived MSCs was induced in
PL supplemented medium [89]. In BICA-loaded hydrogels,
hypertrophic and osteogenic genes were downregulated,
and at the same time, Coll II was upregulated. This suggests
that BICA might be an appropriate inhibitory agent for
hypertrophy. In the presence of BICA, the groups contain-
ing PL also showed the highest GAG secretion.
Histological staining was performed to detect the extra-
cellular matrix deposition in the cell-laden hydrogels. The
chondrogenic differentiation of hBM-MSCs was confirmed
in both conditions, with and without BICA, by deposition
of cartilage ECM and a spherical cellular phenotype.
Among the hydrogels with different combinations of
Alg, CS, and PL, the hydrogel containing all three was se-
lected as the most appropriate hydrogel due to its better
performance, as assessed by mRNA, biochemical, and
histological analysis. It has been shown that mechanical
loading applied to MSCs induces chondrogenesis [95, 96].
It has also been demonstrated that shear and compressive
load applied to MSCs embedded in fibrin-polyurethane
scaffolds induced chondrogenesis [55–57]. Accordingly,
complex load applied to hBM-MSCs in Alg-CS-PL was
studied in the presence or absence of BICA. The expres-
sion level of MMP-13 confirmed the data previously ob-
tained without the shear loading and indicated the
effectiveness of BICA in inhibiting hypertrophy genes.
Mechanical loading induced GAG production regardless
of the presence of BICA, which confirmed the effect of
mechanical loading on enhanced matrix synthesis. Total
collagen secretion was not significantly affected by the
mechanical loading, which suggests that the increase in
collagen type 2 secretion opposed the decrease of collagen
types 1 and 10. However, collagen types 1, 2, and 10
should be measured separately at post-translational level
in order to confirm this.
Conclusion
In conclusion, PL and CS enhance the mechanical proper-
ties and support cell viability in combination with Alg
hydrogel. The results presented in this study showed that
the tri-part hydrogel composed of Alg, CS, and PL can
induce chondrogenic differentiation of hBM-MSCs by the
upregulation of collagen type 2 and aggrecan. Also, it was
shown that addition of BICA inhibited hypertrophy during
chondrogenic differentiation of hBM-MSCs. Moreover,
our results indicate that BICA improves hBM-MSCs
differentiation into chondrocytes as it increases the ex-
pression level of chondrogenic genes as well as GAG and
collagen deposition. In order to mimic the physiological
environment of chondrocytes, a mechanical shear loading
simulation was also provided. It is demonstrated that the
applied loading regimen induces chondrogenic differenti-
ation in case of GAG secretion.
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typical CD markers related to MSC (CD 44 and CD 90, CD73, CD105).
Other antigens were also expressed in a minority of the cells. S-Fig. 3.
Differentiation potential of the isolated cells from human Bone Marrow.
A) Sections prepared from micromass culture for chondrogenesis stained
purple following toluidine blue staining, B) Osteogenic culture stained
red following alizarin red staining. C) Adipogenic culture stained red fol-
lowing oil red staining. Culture conditions and staining methods were as
previously described (Meury at al., Cell Biochem. 2006 Jul 1;98(4):992–
1006).
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